Clinical significance of human kallikrein 12 gene expression in gastric cancer

doi:10.3748/wjg.v18.i45.6597

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3896)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

358

HTML

3251

Figures (1-7)

176

Tables (1-1)

111

Sum=3896

Dec 7, 2012 (publication date) through Apr 30, 2024

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Dec 7, 2012; 18(45): 6597-6604
Published online Dec 7, 2012. doi: 10.3748/wjg.v18.i45.6597

Full Size Figure Download Figure

Figure 6 Reduction of cell proliferation by methylthiazolyltetrazolium assay after silencing the kallikrein 12. The proliferative ability significantly decreased in MKN-45 cells after transfection with kallikrein 12 small interfering RNA (siRNA), especially from the 3rd to 5th days of the assay. Data are shown as mean ± SD, using the one-way analysis of variance test (P = 0.001). MTT: Methylthiazolyltetrazolium.

Citation: Zhao EH, Shen ZY, Liu H, Jin X, Cao H. Clinical significance of human kallikrein 12 gene expression in gastric cancer. World J Gastroenterol 2012; 18(45): 6597-6604
URL: https://www.wjgnet.com/1007-9327/full/v18/i45/6597.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i45.6597